Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 June 2024
m 03:43 | Cytarabine (Ara-C) diffhist +156 Jwarner talk contribs →History of changes in PMDA indication |
m 03:31 | Lisocabtagene maraleucel (Breyanzi) diffhist +340 Jwarner talk contribs |
28 May 2024
m 23:12 | Allogeneic HSCT diffhist +605 Jwarner talk contribs →References |
m 23:03 | Allopurinol (Zyloprim) diffhist +729 Jwarner talk contribs |
26 May 2024
m 12:55 | Rituximab (Rituxan) diffhist -13 Jwarner talk contribs →Also known as |
23 May 2024
|
m 11:59 | How I Treat 2 changes history +237 [Jwarner (2×)] | |||
m |
|
11:59 (cur | prev) +1 Jwarner talk contribs →=Acute respiratory failure | |||
m |
|
11:58 (cur | prev) +236 Jwarner talk contribs →Atrial fibrillation |
17 May 2024
16 May 2024
m 17:05 | Lisocabtagene maraleucel (Breyanzi) diffhist +291 Jwarner talk contribs |
N 00:22 | Chronic lymphocytic leukemia - null regimens diffhist +16,785 Jwarner talk contribs Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;..." |